The relationships between cognitive impairment that exist during the clinical course of
multiple sclerosis (MS) remain poorly described. The effect of disease duration has been …

Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system that is
characterised by inflammatory damage to the myelin sheath. Though often neglected …

Background: There is limited and inconsistent information on the clinical determinants of
cognitive impairment (CI) in multiple sclerosis (MS). Objective: The aim of this study was to …

The Canadian Multiple Sclerosis Working Group has updated its treatment optimization
recommendations (TORs) on the optimal use of disease-modifying therapies for patients …

Objective Disease-modifying treatments (DMTs) are the gold standard for slowing disability
progression in multiple sclerosis (MS), but their effects on cognitive impairment, a key …

Cognitive impairment (CI) is common and debilitating in patients with multiple sclerosis.
However, little is known about how different disease courses affect CI, impeding prognosis …

Purpose Multiple sclerosis (MS) is a chronic condition linked to a wide range of
psychological difficulties. While traditional cognitive behavioural therapy has been studied …

Age is associated with increased risk for several disorders including dementias,
cardiovascular disease, atherosclerosis, obesity, and diabetes. Age is also associated with …

Aging is one of the main risk factors for the development of many neurodegenerative
diseases. Emerging evidence has acknowledged neuroinflammation as potential trigger of …

Executive Functioning: A Comprehensive Guide for Clinical Practice is the first book to offer
an in-depth, comprehensive, and clinically applicable analysis of executive functioning (EF) …